TY  - JOUR
AU  - Artacho Ruiz, R
AU  - Artacho Jurado, B
AU  - Caballero Güeto, F
AU  - Cano Yuste, A
AU  - Durbán García, I
AU  - García Delgado, F
AU  - Guzmán Pérez, J A
AU  - López Obispo, M
AU  - Quero Del Río, I
AU  - Rivera Espinar, F
AU  - Del Campo Molina, E
PY  - 2019
DO  - 10.1016/j.medin.2019.07.012
UR  - http://hdl.handle.net/10668/14452
T2  - Medicina intensiva
AB  - High-flow nasal cannula (HFNC) therapy is used in the treatment of acute respiratory failure (ARF) and is both safe and effective in reversing hypoxemia. In order to minimize mortality and clinical complications associated to this practice, a series...
LA  - en
KW  - Acute respiratory failure
KW  - Cánula nasal de alto flujo
KW  - Fallo respiratorio agudo
KW  - High-flow nasal cannula
KW  - Hipoxemia
KW  - Hypoxemia
KW  - Predictores de éxito
KW  - Predictors of success
KW  - ROX index
KW  - Índice ROX
TI  - Predictors of success of high-flow nasal cannula in the treatment of acute hypoxemic respiratory failure.
T2  - Predictores de éxito del tratamiento con cánula nasal de alto flujo en el fallo respiratorio agudo hipoxémico.
TY  - research article
VL  - 45
ER  -